V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214979 | 20130172 | 1.76 | 93.2 | null | 2015-05-10 | 2017-09-07 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100523287 |
| 20214981 | 20130173 | 0 | 92.3 | Palliative (P) | 2017-02-26 | 2017-03-29 | EOX | 02 | Y | EOX | 100274102 |
| 20214982 | 20130174 | 1.57 | 95 | Palliative (P) | 2016-11-16 | 2016-11-16 | CETUXIMAB + IRINOTECAN + MDG | Y | N | CETUXIMAB + IRINOTECAN + MDG | 100293986 |
| 20214983 | 20130175 | 1.88 | 73 | null | 2015-09-14 | 2017-08-25 | Trial Unspecified | 2 | null | TRIAL | 101708350 |
| 20214984 | 20130176 | 0 | 46 | null | 2021-02-11 | 2021-02-25 | EOX | 02 | null | SORAFENIB | 101056184 |
| 20214985 | 20130177 | 1.59 | 77.5 | Neo-adjuvant (N) | 2018-04-28 | 2018-10-18 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101837086 |
| 20214987 | 20130178 | null | null | Palliative (P) | 2017-01-05 | 2017-01-13 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101329346 |
| 20214989 | 20130179 | 1.52 | 59.05 | null | 2019-05-27 | 2019-05-27 | FLUOROURACIL + IRINOTECAN + Panitumumab | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100874532 |
| 20214990 | 20130180 | 1.82 | 87 | Palliative (P) | 2019-02-03 | 2019-02-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101683143 |
| 20214994 | 20130181 | 1.86 | 68.8 | Palliative (P) | 2018-04-05 | 2018-04-14 | Sorafenib | 02 | N | SORAFENIB | 100777372 |
| 20214995 | 20130182 | 1.6 | 85.4 | Palliative (P) | 2018-02-19 | 2018-05-30 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101342111 |
| 20214996 | 20130183 | null | 54.55 | Palliative (P) | 2019-07-16 | 2019-07-30 | EOX | N | Y | EOX | 101827991 |
| 20214998 | 20130184 | 1.66 | 102.6 | Palliative (P) | 2019-02-25 | 2019-11-02 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100562720 |
| 20214999 | 20130185 | 1.72 | null | Curative (C) | 2019-09-14 | 2019-10-08 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101838997 |
| 20215000 | 20130186 | 1.78 | 65 | null | 2016-11-22 | 2018-06-18 | IRINOTECAN + MDG + PANITUMUMAB | Y | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101028630 |
| 20215001 | 20130187 | 1.74 | 104.9 | null | 2018-06-25 | 2018-06-25 | Trial Unspecified | 02 | N | CAPECITABINE + RT | 101746171 |
| 20215003 | 20130188 | 1.75 | 99.5 | null | 2016-11-02 | 2017-03-09 | EOX | N | null | EOX | 101564000 |
| 20215005 | 20130189 | 1.78 | 88.9 | null | 2015-10-06 | 2015-10-11 | CETUXIMAB + IRINOTECAN + MDG | 1 | null | CETUXIMAB + IRINOTECAN + MDG | 101757701 |
| 20215007 | 20130190 | 0 | 75 | null | 2017-03-09 | 2017-05-04 | Sorafenib | 02 | null | SORAFENIB | 100540303 |
| 20215008 | 20130191 | 1.69 | 63.6 | null | 2018-02-26 | 2018-03-15 | EOX | 99 | Y | CETUXIMAB + IRINOTECAN + MDG | 101363561 |
| 20215011 | 20130192 | 1.86 | 85 | Palliative (P) | 2017-12-17 | 2020-01-25 | EOX | 02 | N | SORAFENIB | 100497948 |
| 20215013 | 20130193 | 1.78 | 0 | Palliative (P) | 2020-08-21 | 2020-08-26 | EOX | 02 | N | CAPECITABINE + RT | 101167953 |
| 20215014 | 20130194 | 1.93 | 53.7 | Palliative (P) | 2017-12-04 | 2017-12-04 | Capecitabine 35days + RT | 02 | Y | CAPECITABINE + RT | 100530573 |
| 20215017 | 20130195 | 1.75 | 104.9 | Neo-adjuvant (N) | 2017-07-23 | 2017-08-07 | EOX | 2 | N | CAPECITABINE + RT | 101634349 |
| 20215018 | 20130196 | 1.51 | 83 | Palliative (P) | 2018-05-07 | 2018-06-18 | Trial Unspecified | 02 | N | EOX | 101850217 |
| 20215019 | 20130197 | 1.78 | 62.7 | 03 | 2018-10-18 | 2018-10-21 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 100060602 |
| 20215020 | 20130198 | 1.82 | 121.2 | Palliative (P) | 2020-10-31 | 2020-10-31 | Trial Unspecified | N | N | TRIAL | 101439653 |
| 20215021 | 20130199 | 1.84 | 95.9 | Palliative (P) | 2019-06-15 | 2019-07-21 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101291539 |
| 20215022 | 20130200 | 1.74 | 112 | Palliative (P) | 2019-11-11 | 2019-12-28 | EOX | 02 | N | TRIAL | 100813707 |
| 20215024 | 20130201 | 1.7 | 40.6 | Palliative (P) | 2017-06-07 | 2017-06-15 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100061798 |
| 20215025 | 20130202 | 1.67 | 79 | Palliative (P) | 2018-07-25 | 2018-08-08 | EOX | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 100042753 |
| 20215029 | 20130203 | 0 | 66.95 | Curative (C) | 2018-10-02 | 2018-10-02 | CETUXIMAB + IRINOTECAN + MDG | 1 | N | CETUXIMAB + IRINOTECAN + MDG | 101216153 |
| 20215030 | 20130204 | 1.57 | 68.2 | Palliative (P) | 2019-03-09 | 2019-05-07 | EOX | 2 | N | EOX | 101421837 |
| 20215031 | 20130205 | 1.83 | 63 | Palliative (P) | 2018-06-18 | 2018-08-24 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101232157 |
| 20215035 | 20130206 | 1.75 | 70.8 | Palliative (P) | 2018-07-06 | 2018-08-15 | EOX | 02 | Y | EOX | 101351199 |
| 20215036 | 20130207 | 1.61 | 74.7 | null | 2016-07-27 | 2016-07-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101450021 |
| 20215040 | 20130208 | 1.76 | 61.3 | null | 2022-01-25 | 2022-02-28 | EOX | 02 | N | TRIAL | 100095257 |
| 20215046 | 20130209 | 1.64 | 75 | Palliative (P) | 2019-09-23 | 2019-11-05 | Sorafenib | 02 | N | SORAFENIB | 100005195 |
| 20215047 | 20130210 | 1.85 | 107 | Neo-adjuvant (N) | 2015-02-17 | 2019-04-19 | Cetuximab + FOLFIRI cycle1 | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100699655 |
| 20215049 | 20130211 | 1.64 | 87.2 | Curative (C) | 2018-10-14 | 2018-10-26 | EOX | 02 | N | EOX | 101655671 |
| 20215050 | 20130212 | 1.57 | 93.3 | Palliative (P) | 2020-06-19 | 2020-06-19 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 100159587 |
| 20215051 | 20130213 | 1.6 | 76.5 | Curative (C) | 2016-01-12 | 2016-04-29 | Sorafenib | Y | Y | SORAFENIB | 100625264 |
| 20215052 | 20130214 | 1.61 | 93.2 | Palliative (P) | 2015-09-17 | 2015-09-25 | Trial Unspecified | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101748537 |
| 20215053 | 20130215 | 1.69 | 93.1 | Palliative (P) | 2020-04-07 | 2020-04-07 | Oxaliplatin + Raltitrexed | Y | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100815574 |
| 20215054 | 20130216 | 1.7 | 66 | Palliative (P) | 2018-10-23 | 2018-11-21 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101816778 |
| 20215058 | 20130217 | 1.65 | 95.3 | Palliative (P) | 2017-03-06 | 2017-03-06 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100328862 |
| 20215061 | 20130218 | 1.62 | 129.2 | null | 2019-03-10 | 2019-03-31 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100336048 |
| 20215062 | 20130219 | null | 54.6 | Palliative (P) | 2017-02-07 | 2017-02-10 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101550124 |
| 20215063 | 20130220 | 1.76 | 63.2 | Palliative (P) | 2020-09-16 | 2020-10-06 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 01 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100228842 |
| 20215066 | 20130221 | 1.69 | 75 | Palliative (P) | 2016-07-29 | 2016-07-30 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100416258 |